·   Log in

Archive for March 3rd, 2010

Alzheimer’s drug Dimedon from Pfizer and Medication fails in crucial clinical study

Wednesday, March 3, 2010 20:43

Dimebon (latrepirdine) an investigational drug to treat Alzheimer's disease failed in late phase clinical studies, Pfizer Inc and Medivation, Inc, the developers of the drug which was thought to be promising lead, announced.

This was posted under category: Clinical Trials  |  Read Full Story  |  0 Comments
Tagged with: , ,

Abbott and Enanta develop three new drugs to treat hepatitis C

Wednesday, March 3, 2010 17:28

Abbott and its research partner Enanta Pharmaceuticals will start clinical studies to evaluate three antiviral agents to hepatitis C (HCV) infection.

This was posted under category: Clinical Trials  |  Read Full Story  |  0 Comments
Tagged with: ,

Aurobindo’s cefuroxime antibiotic pills get Canadian approval

Wednesday, March 3, 2010 15:57

Aurobindo Pharma, a leading APIs and generic formulations maker from India, has secured marketing approval for cefuroxime antibiotic pills in Canada, the company announced.

This was posted under category: Industry  |  Read Full Story  |  0 Comments
Tagged with: ,

Panacea Biotech to supply egg-derived H1N1 vaccine to government as India reports 1376 deaths from swine flu as on March 2, 2010

Wednesday, March 3, 2010 12:58

Panacea Biotec has entered into an advance marketing agreement with Ministry of Health and Family Welfare (MoHWF) for supplying its H1N1 swine flu vaccine Pandyflu.

This was posted under category: Industry  |  Read Full Story  |  0 Comments

US FDA stops Ranbaxy’s generic tamsulosin (Flomax) due to poor compliance of GMP in manufacturing plants

Wednesday, March 3, 2010 11:37

US FDA has denied approval for Daiichi-Ranbaxy's generic tamsulosin hydrochloride tablets to treat  enlarged prostate due to the ongoing controversy on good manufacturing practice norms violations, reports said.

This was posted under category: Industry  |  Read Full Story  |  0 Comments

India tightens regulations on stem cell research

Wednesday, March 3, 2010 9:13

Government of India has drawn up a plan to effectively review and monitor the way stem cell research being conducted in the country, according to reports.

This was posted under category: Biotech  |  Read Full Story  |  0 Comments